Review article: the clinical pharmacology of proton pump inhibitors
@article{Sachs2006ReviewAT, title={Review article: the clinical pharmacology of proton pump inhibitors}, author={G. Sachs and J. M. Shin and C. Howden}, journal={Alimentary Pharmacology & Therapeutics}, year={2006}, volume={23} }
Proton pump inhibitors inhibit the gastric H+/K+‐ATPase via covalent binding to cysteine residues of the proton pump. All proton pump inhibitors must undergo acid accumulation in the parietal cell through protonation, followed by activation mediated by a second protonation at the active secretory canaliculus of the parietal cell.
Topics from this paper
Paper Mentions
Interventional Clinical Trial
Find out if there is a significant difference between clinical outcome among the patients
with bleeding peptic ulcer treated with oral omeprazole compared to those treated with… Expand
Conditions | Bleeding Peptic Ulcer |
---|---|
Intervention | Drug |
269 Citations
Proton pump inhibitors: actions and reactions.
- Chemistry, Medicine
- Drug discovery today
- 2009
- 85
- Highly Influenced
Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy
- Medicine
- Front. Pharmacol.
- 2017
- 22
Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904‐Z
- Chemistry, Medicine
- Alimentary pharmacology & therapeutics
- 2008
- 47
Safe use of proton pump inhibitors in patients with cirrhosis
- Medicine
- British journal of clinical pharmacology
- 2018
- 18
- PDF
Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy
- Medicine
- Alimentary pharmacology & therapeutics
- 2009
- 109
- PDF
References
SHOWING 1-10 OF 35 REFERENCES
Review article: immediate‐release proton‐pump inhibitor therapy – potential advantages
- Chemistry, Medicine
- Alimentary pharmacology & therapeutics
- 2005
- 71
Physiology of the Parietal Cell and Therapeutic Implications
- Chemistry, Medicine
- Pharmacotherapy
- 2003
- 32
Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors.
- Chemistry, Medicine
- Journal of the American Chemical Society
- 2004
- 203
Restoration of acid secretion following treatment with proton pump inhibitors.
- Chemistry, Medicine
- Gastroenterology
- 2002
- 88
Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half‐life: effects on intragastric pH and comparison with esomeprazole in healthy volunteers
- Medicine
- Alimentary pharmacology & therapeutics
- 2004
- 82
Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo.
- Chemistry, Medicine
- Biochemical pharmacology
- 2004
- 51
Improving on PPI-based therapy of GORD.
- Medicine
- European journal of gastroenterology & hepatology
- 2001
- 43
Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases.
- Medicine
- Pharmacology & therapeutics
- 2005
- 131
The site of action of pantoprazole in the gastric H+/K(+)-ATPase.
- Chemistry, Medicine
- Biochimica et biophysica acta
- 1993
- 100
Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.
- Chemistry, Medicine
- Biochemical pharmacology
- 2006
- 48